Risedronate compositions and their methods of use

Details Risedronate compositions and their methods of use Risedronate compositions and their methods of use

A - Human Necessities

61

K

A61K 31/675 (2006.01) A61P 19/10 (2006.01)

Patent

CA 2564898

A method comprising orally administering to a human or other mammal a pharmaceutical composition comprising from about 65% to about 110% of the cumulative effective dose of risedronate or a pharmaceutically acceptable acid, salt, ester, solvate, or polymorph thereof according to a continuous dosing schedule of one, two, or three consecutive days per month is useful for treating or preventing osteoporosis and other bone metabolic disorders.

Cette invention a pour objet un procédé comprenant l~administration par voie orale, à un être humain ou à un autre mammifère, d~une composition pharmaceutique comprenant entre environ 65 % et environ 110 % de la dose efficace accumulée de risédronate ou d~un acide, d~un sel, d~un ester, d~un solvate ou d~un polymorphe de qualité pharmaceutique, suivant un programme de dosage en continu sur un, deux ou trois jours consécutifs par mois, utile pour le traitement ou la prévention de l~ostéoporose et des autres troubles métaboliques osseux.

Affiliated with

Also associated with

Rating

Risedronate compositions and their methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Risedronate compositions and their methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Risedronate compositions and their methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1833064